Skip to content

A study to test how well different doses of BI 4060107 are tolerated by people with advanced cancer (solid tumours)

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525187-18-00
Enrollment
15
Registered
2026-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumours

Interventions

None listed

Sponsors

Aimed Bio lnc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 2, 2026